Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroma Security Regulatory News (CSSG)

Share Price Information for Croma Security (CSSG)

Share Price is delayed by 15 minutes
Get Live Data
67.50    0.00 (0.00%)
Bid:
65.00
Ask:
70.00
Spread: 5.00 (7.692%)
Market Cap: £9.29m
CSSG Live PriceLast checked at - London Stock Exchange

Intraday Croma Security Share Chart

Contract Wins

22 Mar 2011 07:00

RNS Number : 3554D
Croma Group PLC
22 March 2011
 



Croma Group PLC ("Croma" or "the Group")

 

New Contract Wins

 

Croma, the AIM listed asset protection, manned guarding, access security, and avionics specialist, is delighted to announce three new contract awards.

 

Photobase, Croma's access security and installation systems subsidiary, has secured three new contracts for the Group's proprietary FastVein™ technology, which provides a complete biometric identification system. The FastVein™ technology is currently in production and due to be launched in April 2011.

 

The details of these contracts are as follows:

 

- Photobase, in association with CSS Group, has been appointed to distribute and provide frontline technical support for the Hitachi H1 Finger Vein Scanner (the "H1 Scanner") in the United States. Photobase is currently the sole distributor of the H1 Scanner in the UK. The H1 Scanner uses Photobase's proprietary FastVein™ API and offers the ability to deploy multiple scanners on a single system.

 

- Photobase has been appointed by HMP Wealstun to provide Biometric Prisoner and Visitor systems for the prison, using FastVein™ technology. FastVein™ will provide a complete biometric identification system and will enable HMPS to interface directly with the National Offender Management Information System.

 

- Photobase has also been appointed to upgrade the existing Prisoner ID Management system at HMP Northallerton to include FastVein™ Biometrics. Arriving prisoners will have their identities checked and instantly verified using FastVein™ technology. This system has been rolled out at ten HM Prisons since March 2010.

 

Commenting on the new contract awards Sebastian Morley, Chief Executive of Croma, said:

 

"We are delighted with the appointment of Photobase by Hitachi as its United States distributor. To be selected as Hitachi's partner is a strong endorsement of the software we have developed for this system and this new contract presents a significant commercial opportunity to target the US market.

 

In addition, two more UK prisons have chosen our new finger vein reader technology. This not only verifies our finger vein scanner as the most sophisticated and robust biometric system in the market, it also provides us with opportunities to upgrade incumbent systems and target new commercial markets". 

 

Croma Group PLC:

Sebastian Morley, CEO

Tel: 07768 006909

Brewin Dolphin (NOMAD):

Sandy Fraser, Managing Director - Corporate Finance

Tel: 0845 213 2072

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTPGUGGWUPGPGG
Date   Source Headline
16th Mar 20267:00 amRNSAcquisition
16th Mar 20267:00 amRNSAcquisition
26th Feb 20267:00 amRNSHalf-year Financial Report
23rd Feb 20264:58 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSNotice of Results
15th Jan 20268:32 amRNSDirector Dealing
5th Jan 20267:00 amRNSAcquisition
1st Dec 202511:30 amRNSResult of AGM
25th Nov 20257:00 amRNSNotice of AGM
3rd Nov 20257:00 amRNSFinal Results
30th Oct 20257:00 amRNSNotice of Results and Investor Presentation
23rd Oct 20257:00 amRNSDirectorate Change
5th Sep 20251:59 pmRNSBoard Change
2nd Sep 20253:29 pmRNSBoard Change
16th Jul 202511:19 amRNSHolding(s) in Company
9th Jul 20257:00 amRNSTrading Statement
8th May 20253:55 pmRNSDirector/PCA Dealings
25th Apr 20256:10 pmRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSAcquisition
6th Mar 20257:00 amRNSGrant of Options
24th Feb 20257:00 amRNSHalf-year Report
19th Feb 20257:00 amRNSNotice of Results and Investor Presentations
3rd Feb 20257:00 amRNSAcquisition
20th Jan 20257:00 amRNSTrading Statement
4th Dec 20249:26 amRNSResult of AGM
4th Dec 20247:00 amRNSAGM Statement
28th Nov 20247:00 amRNSNotice of AGM
5th Nov 202411:10 amRNSDirector Dealing
5th Nov 20247:00 amRNSNotice of Investor Presentation
4th Nov 20247:00 amRNSFinal Results
29th Oct 20242:38 pmRNSDirector/PCA Dealings
14th Aug 20247:00 amRNSHolding(s) in Company
22nd Jul 20247:00 amRNSTrading Statement
15th Jul 20247:00 amRNSChange of Adviser
8th Jul 20247:00 amRNSReceipt of Deferred Consideration
3rd Apr 20247:00 amRNSNHS Contract Win
21st Feb 20247:00 amRNSHalf-year Report
29th Jan 20247:00 amRNSTrading Statement
8th Jan 20247:00 amRNSAcquisition
1st Dec 202310:24 amRNSResult of AGM
16th Nov 20237:00 amRNSNotice of AGM
13th Nov 202312:54 pmRNSDirector Dealing
13th Nov 20237:00 amRNSGrant of Options
8th Nov 20237:00 amRNSNotice of Investor Presentation
7th Nov 20237:00 amRNSFinal Results
26th Oct 20232:42 pmRNSTransaction in own shares and total voting rights
26th Oct 20237:00 amRNSTransaction in own shares and total voting rights
8th Aug 202310:17 amRNSHolding(s) in Company
7th Aug 202311:10 amRNSHolding(s) in Company
4th Aug 20237:00 amRNSTransaction in Own Shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.